Company Profile
CEO
Mr. Kim Kelderman(CEO, President & Director)
Sector
Healthcare
Industry
Biotechnology
Employees
3.1K
Beta
1.36
Forward P/E
25.8
52W High
$72.16
52W Low
$43.20
Profit Margin
9.0%
Operating Margin
25.2%
Return on Equity
5.3%
Revenue Growth
-1.5%
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biol...
Valuation
Market Cap$8.24B
P/E (TTM)76.32
P/S (TTM)6.62
EV/EBITDA--
Cash Flow
FCF Yield+3.8%
SBC Adj. FCF Yield+3.3%
SBC Impact13.5%
Margins & Growth
Profit Margin16.4%
Operating Margin24.2%
Revenue YoY-1.5%
Earnings YoY126.0%
Balance
Cash$209.82M
Debt--
Net Cash--
Dividend
Dividend Yield0.61%
Payout Ratio24.5%
Quarterly Payout$12.52M